Thu Apr 14, 2011, 01:30 PM
|
|
Member
|
|
Join Date: Aug 2010
Location: Burlington,Ontario,Canada
Posts: 186
|
|
|
FDA Safety Reassessment
__________________
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%  )  47,XY,del(5) (q22q35),+21[24][cp24]/46,XY(1).
|